News

Phase 2b study starts for vaccine against liver cancer

Country
France

Transgene SA of France and Jennerex Inc of the US have announced the start of a Phase 2b study of a vaccine for patients with advanced liver cancer who have failed prior treatment with sorafenib, the only approved drug for the disease.

TiGenix gives update on cell therapy

Country
Belgium

TiGenix NV said that group revenues for the first nine months of 2011 were €1.1 million of which the majority was generated by the company’s cell-based therapy to treat knee injuries, ChondroCelect. Cash at 30 September 2011 was €20.5 million.

Sanofi results better in third quarter than for nine months

Country
France

Sanofi produced considerably better results in the third quarter than its record for the first nine months, opening the possibility that loss of patent protection on certain drugs will be less of a drag on its accounts going into the future.

 

 

 

Oxford BioMedica in glaucoma R&D deal

Country
United States

Oxford BioMedica Plc has entered into a research and development collaboration with the Mayo Clinic in the US to develop a gene therapy for the treatment of chronic glaucoma. It is the company’s second partnership in the area of eye disease.

GSK in $3 billion settlement with the US

Country
United Kingdom

GlaxoSmithKline Plc said it has reached an agreement in principle with the US government to pay $3 billion to settle civil and criminal investigations relating to sales and marketing practices, including those for Avandia (rosiglitazone).

FDA approves artificial heart valve

Country
United States

The US Food and Drug Administration has approved the first artificial heart valve for use in patients with a damaged valve and who are not eligible for open-heart surgery. The device is manufactured by Edwards Lifesciences LLC in the US.

FDA approves new device to repair abdominal aneurysms

Country
United States

The US Food and Drug Administration has approved a new medical device that gives patients with small arteries the option of less invasive surgery to repair abdominal aortic aneurysms. The device is manufactured by TriVascular Inc of California.

Transgene to start cancer vaccine trial

Country
France

Transgene SA said it expects to start recruiting patients in December for a Phase 2b study of its cancer vaccine, TG4010, in patients with advanced non-small cell lung cancer. This follows regulatory approvals in the UK and France with further approvals expected soon.

Bavarian Nordic receives $25 million milestone

Country
Denmark

Bavarian Nordic A/S has announced receipt of a $25 million milestone payment from the US government in connection with the scaling up of production of its smallpox vaccine, Imvamune, for delivery to the US national strategic stockpile.

Shire reports 24% rise in revenue in Q3

Country
United Kingdom

Shire Plc has reported a 24% increase in revenue to $1,086 in the third quarter from a year earlier while operating income was up by 15% to $341 million on the basis of an accounting measure that excludes non-recurring items. This is a non GAAP measure.